Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists


Search by Name:

About Knox Henderson

Knox Henderson
Knox Henderson, Knox Communications
Knox Henderson is a former securities trader on the Canadian equities markets and is now a journalist and capital markets communications consultant. With over 25 years of experience, he has advised a diverse range of small-cap companies across the resource, life sciences, and technology sectors, providing strategic insights and communication strategies to support their growth and visibility in the market.


Knox Henderson's Most Recent Articles

NervGen: Are amazing human trial results leaking out?

NervGen Pharma Corp. (TSXV:NGEN) hopes to commercialize the world’s first ever FDA-approved drug...

Knox Henderson | July 2, 2024

Can NervGen keep a lid on explosive news?

Is NervGen Pharma Corp. (TSXV:NGEN; OTCQX:NGENF) struggling to keep a lid on explosively...

Knox Henderson | March 20, 2024

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma (TSX-V:NGEN) is destined to be one of the top...

Knox Henderson | February 1, 2024

Draganfly Holds 'Pole Position' in Race for Drone Supremacy After Chinese Barred from US Market

The company establishes a toehold with U.S. government, homeland security and military...

Knox Henderson | March 3, 2020

Cannabis Producers Have Everything to Gain From Shift in US Regulation and Public Sentiment

Knox Henderson | April 27, 2018

Featured Company